Abstract
The results of studies on association between CTLA-4 exon-1 +49A/G (rs231775) polymorphism and susceptibility to systemic lupus erythematosus are controversial. To derive a more precise estimation of the relationship between the CTLA-4 exon-1 +49A/G polymorphism and SLE, a meta-analysis of 18 published case–control studies was performed. 18 studies meeting our inclusion criteria comprising 1806 SLE cases and 2,490 controls were included. The effect summary odds ratio (OR) and 95 % confidence intervals were obtained. Publication bias was tested by funnel plot, Egger’s test and heterogeneity was assessed. The combined results showed that there were significant differences in genotype distribution between SLE cases and control on the basis of all studies, GG versus AA (OR = 1.53, 95 % CI: 1.12–2.10), GG versus GA/AA (OR = 1.30, 95 % CI: 1.04–1.64), GG versus GA (OR = 1.27, 95 % CI: 1.03–1.55). When stratifying for the race, the phenomenon was found that SLE cases had a significantly higher frequency of GG/GA versus AA (OR = 1.58, 95 % CI: 1.23–2.03), GG versus AA (OR = 1.89, 95 % CI: 1.23–2.91), GG versus GA/AA(OR = 1.39, 95 % CI: 1.03–1.89), GA versus AA(OR = 1.38, 95 % CI: 1.06–1.80) and G versus A(OR = 1.34, 95 % CI: 1.07–1.67) than control in Asians. Our meta-analysis results suggest that CTLA-4 exon-1 +49A/G polymorphism might be a risk factor for SLE susceptibility, at least in Asians. The large sample and well-designed study based on different ethnic groups should be considered in future associated studies to clarify the association of CTLA-4 exon-1 +49A/G polymorphism with SLE susceptibility.

Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Millis JA (1994) Systemic lupus erythematosus. N Engl J Med 330:1871–1879
Kotzin BL (1996) Systemic lupus erythematosus. Cell 85:303–306
Croker JA, Kimberly RP (2005) Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol 17:529–537
Prokunina L, Alarcon-Riquelme M (2004) The genetic basis of systemic lupus erythematosus knowledge of today and thoughts for tomorrow. Hum Mol Genet 13:R143–R148
Brunet JF, Denizot F, Luciani MF et al (1987) A new member of the immunoglobulin superfamily-CTLA-4. Nature 328:267–270
June CH, Bluestone JA, Nadler LM et al (1994) The B7 and CD28 receptor families. Immunol Today 15:321–331
Salomon B, Bluestone JA (2001) Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19:225–252
Lee JH, Wang LC, Lin YT et al (2006) Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 117:280–286
Ueda H, Howson JM, Esposito L et al (2003) Association of the T cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature 423:506–511
Ahmed S, Ihara K, Kanemitsu S et al (2001) Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford) 40:662–667
Feng ZL (2005) CTLA-4 exon-1 +49A/G polymorphism associated with SLE and RA and expression of soluble CTLA-4 in patients with SLE and RA. Dissertation, Shandong University (in Chinese)
Pyo CW, Choi HB, Choi HJ et al (2000) The distribution of CTLA-4 Alleles in Korean patients with SLE. Korean J Immunol 22:17–22 In Korea
Aguilar F, Torres B, Sanchez-Roman J et al (2003) CTLA-4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum Immunol 64:936–940
Pullmann R, Lukac J, Skerenova M et al (1999) Cytotoxic T lymphocyte antigen 4(CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol 17:725–729
Ulker M, Yazisiz V, Sallakci N et al (2009) The association of CTLA-4 exon-1 +49A/G polymorphism with systemic lupus erythematosus. Int J Immunogenet 36:245–250
Zhou Y, Xiao LS (2010) Polymorphism of CTLA-4 gene in SLE patients and its association with ANA or anti-dsDNA antibody. Chin J Clin Lab Sci 28:48–50 (Chinese)
Barreto M, Santos E, Ferreira R et al (2004) Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 12:620–626 (In Chinese)
Heward J, Gordon C, Allahabadia A et al (1999) The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus. Ann Rheum Dis 58:193–195
Hudson LL, Rocca K, Song YW et al (2002) CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet 111:452–455
Lee YH, Kim YR, Ji JD et al (2001) Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus. Lupus 10:601–605
Matsushita M, Tsuchiya N, Shiota M et al (1999) Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method. Tissue Antigens 54:578–584
Takeuchi F, Kawasugi K, Nabeta H et al (2003) CTLA-4 dimorphisms in Japanese patients with systemic lupus erythematosus. Clin Exp Rheumatol 21:527–528
Peng XB, Zhu XL (2001) Study on the associatIon between CTLA-4 gene polymorphism and systemic lupus erythematosus. Immunol J 117:399–401 in Chinese
Parks CG, Hudson LL, Cooper GS et al (2004) CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. Lupus 13:784–791
Chua KH, Puah SM, Chew CH et al (2010) Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Ann Hum Biol 37:274–280
Yu XP, Song JQ, Maji Moses et al (2010) Association of CTLA -4 gene polymorphisms with systemic lupus ERYTHEMATOSUS. Med J Wuhan Univ 31:439–446 in Chinese
Lee YH, Harley JB, Nath SK (2005) CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet 116:361–367 Chinese
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
Petitti DB (1994) Meta-analysis, decision analysis, and cost-effectiveness analysis. Oxford University Press, New York
Egger M, Davey SG, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Liu MF, Wang CR, Lin LC et al (2001) CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus 10:647–649
Jin FY (2009) The association of CTLA-4 exon-1 +49A/G polymorphis with Systemic lupus erythematosus. Dissertation, Kunming Medical College (in chinese)
D’Alfonso S, Rampi M, Bocchio D et al (2000) Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum 43:120–128
Eagar T, Karandikar N, Bluestone J et al (2002) The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur J Immunol 32:972–981
Acknowledgments
The authors wish to thank all families for participating in this study. And we thank editors of Molecular Biology Reports for editing the manuscript.
Conflict of interest
No conflict of interest had been declared by the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Wei-wei Chang and Liu Zhang contributed equally to this work and should be considered as co-first authors.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chang, Ww., Zhang, L., Yao, Ys. et al. Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis. Mol Biol Rep 39, 9159–9165 (2012). https://doi.org/10.1007/s11033-012-1788-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-1788-4


